DANIMER SCIENTIFIC, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.729 USD | +2.79% |
|
-6.34% | -27.72% |
| May. 22 | Jefferies Downgrades Danimer Scientific to Hold From Buy | MT |
| May. 20 | Danimer Scientific Says CEO Steve Croskrey Retiring | MT |
Financials (USD)
| Sales 2024 * | 73.96M | Sales 2025 * | 145M | Capitalization | 82.58M |
|---|---|---|---|---|---|
| Net income 2024 * | -98M | Net income 2025 * | -66M | EV / Sales 2024 * | 1.12 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.57 x |
| P/E ratio 2024 * |
-0.8
x | P/E ratio 2025 * |
-1.3
x | Employees | 257 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.22% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danimer Scientific, Inc.
More recommendations
More press releases
| 1 day | -7.22% | ||
| 1 week | -5.78% | ||
| Current month | -5.44% | ||
| 1 month | -16.42% | ||
| 3 months | -33.72% | ||
| 6 months | -36.11% | ||
| Current year | -30.47% |
1 week
0.69
0.82
1 month
0.690.88
Current year
0.601.84
1 year
0.603.49
3 years
0.6029.50
5 years
0.6066.30
10 years
0.6066.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 16-01-31 | |
Michael Hajost
DFI | Director of Finance/CFO | 60 | 22-02-28 |
| Chief Tech/Sci/R&D Officer | 47 | 20-12-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cynthia R. Cohen
BRD | Director/Board Member | 71 | 22-08-10 |
Greg Hunt
BRD | Director/Board Member | 68 | 19-05-31 |
| Director/Board Member | 59 | 22-08-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 9 M€ | +9.29% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 0.7373 | +3.96% | 50 739 |
| 24-05-23 | 0.7092 | -7.22% | 892,937 |
| 24-05-22 | 0.7644 | -5.47% | 594,635 |
| 24-05-21 | 0.8086 | +1.33% | 537,858 |
| 24-05-20 | 0.798 | +1.37% | 484,876 |
Delayed Quote Nyse, May 23, 2024 at 04:00 pm EDT
More quotes
Danimer Scientific, Inc. is a performance polymer company. The Company specializes in bioplastic replacements for traditional petroleum-based plastics. Its technologies include Polyhydroxyalkanoate (PHA)-based Resins, Polylactic acid (PLA)-based Resins and Rinnovo. It harvests the PHA from the bacteria, then purifies and filters the bioplastic before forming the non-formulated PHA into pellets. Its PHA is a naturally occurring bioplastic that effectively biodegrades in both anaerobic environments, such as a waste treatment facility, and aerobic environments. It sells the PHA under its proprietary Nodax brand name. PLA is made from dextrose derived from corn, sugar beets and sugar cane, among other sources. Applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. The Company primarily markets its products to consumer packaging brand owners, converters and manufacturers in the plastics industry.
Sector
Commodity Chemicals
Calendar
2024-07-08
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
0.7092
USD
Average target price
1.41
USD
Spread / Average Target
+98.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -30.47% | 82.58M | |
| +3.79% | 40.03B | |
| -21.04% | 21.8B | |
| -15.40% | 13.22B | |
| -12.04% | 9.94B | |
| -10.10% | 9.76B | |
| +20.11% | 8.41B | |
| +10.22% | 6.88B | |
| -29.87% | 5.32B | |
| -23.43% | 3.65B |
- Stock Market
- Equities
- DNMR Stock
